Kim Forest Enterprise Co., Ltd. provides various genetic and medical testing services in China and the United States. The company provides genetic testing, drug report, and monitoring tools for cancer patients; and GoL Life that provides a non-invasive genome-wide health assessment for healthy persons. It offers bioinformatics service items; prenatal test kits; and genetically modified models. In addition, the company offers SARS-CoV-2 detection kits. Further, it engages in the wholesale of medical instruments and consumables; and provision of various genetic and medical testing services. The company was founded in 2004 and is headquartered in New Taipei City, Taiwan.
Frequently asked questions
What sector does Kim Forest Enterprise Co., Ltd. (6645) operate in?
Kim Forest Enterprise Co., Ltd. belongs to the Other sector and operates in the Diagnostics & Research industry.
What is Kim Forest Enterprise Co., Ltd. (6645) current stock price?
As of the latest data, Kim Forest Enterprise Co., Ltd. stock price is NT$13.25, with a previous close of NT$13.60. Kim Forest Enterprise Co., Ltd. lost -NT$0.35 in the last trading session, representing a -2.57% loss.
What is Kim Forest Enterprise Co., Ltd. (6645) current market capitalization?
Kim Forest Enterprise Co., Ltd. market cap is approximately 800.09 million.
What is Kim Forest Enterprise Co., Ltd. (6645) Earnings Per Share (EPS)?
The trailing EPS is -NT$2.41.
What is Kim Forest Enterprise Co., Ltd. (6645) EBITDA?
Kim Forest Enterprise Co., Ltd. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -23.66 million.
Does Kim Forest Enterprise Co., Ltd. (6645) pay dividends?
No. Kim Forest Enterprise Co., Ltd. does not pay a dividend.
What is Kim Forest Enterprise Co., Ltd. (6645) beta (volatility) score?
Kim Forest Enterprise Co., Ltd. has a beta of -0.006, indicating lower volatility than the overall market.
